SCHEMBL17459709

SCHEMBL17459709

COc1cc(C=CC(=O)OC(C)(C)C)cc(OC)c1OC

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.64
KDM4E B2RXH2 3/20 0.64
HTR1A P08908 2/20 0.64
HPGD P15428 2/20 0.64
GAA P10253 1/20 0.64
HTT P42858 1/20 0.64
HTR2C P28335 1/20 0.64
HSD17B10 Q99714 1/20 0.64
ABCB1 P08183 1/20 0.55
KRAS P01116 5/20 0.54
CA1 P00915 3/20 0.54
CA2 P00918 3/20 0.54
PSMB11 A5LHX3 1/20 0.54
PSMA7 O14818 1/20 0.54
PSMB1 P20618 1/20 0.54
PSMA1 P25786 1/20 0.54
PSMA2 P25787 1/20 0.54
PSMA3 P25788 1/20 0.54
PSMA4 P25789 1/20 0.54
PSMB8 P28062 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17459707 1.00 ALDH1A1 (0.64) ALDH1A1KDM4EHTR1AHPGDGAA
SCHEMBL25141957 0.88 CYP1A2 (0.66) KDM4EGAACYP1A2CYP2D6
SCHEMBL2433925 0.83 ALDH1A1 (0.72) ALDH1A1KDM4EHTR1AHPGDGAA
SCHEMBL2433926 0.83 ALDH1A1 (0.72) ALDH1A1KDM4EHTR1AHPGDGAA
SCHEMBL4054983 0.83 ESR1 (0.45) HTR1AGAAHTTCA1CA2
SCHEMBL4054986 0.83 ESR1 (0.45) HTR1AGAAHTTCA1CA2
SCHEMBL13845311 0.83 ESR1 (0.45) HTR1AGAAHTTCA1CA2
SCHEMBL23610174 0.82 ALDH1A1 (0.60) ALDH1A1KDM4EHTR1AHPGDGAA
SCHEMBL24557862 0.81 BACE1 (0.55) KDM4EGAAABCB1CYP1A1CYP1A2
SCHEMBL26479378 0.81 ALDH1A1 (0.68) ALDH1A1KDM4EHTR1AHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10758524-B2 Compositions and methods for selectively depleting senescent cells BIOVENTURES, LLC (US) 2020-09-01 US disclosed
US-20180369223-A1 COMPOSITIONS AND METHODS FOR SELECTIVELY DEPLETING SENESCENT CELLS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-12-27 US disclosed
US-10071087-B2 Compositions and methods for selectively depleting senescent cells BIOVENTURES, LLC (US) 2018-09-11 US disclosed
US-20170246155-A1 COMPOSITIONS AND METHODS FOR SELECTIVELY DEPLETING SENESCENT CELLS BIOVENTURES, LLC 2017-08-31 US disclosed
EP-3177144-A1 COMPOSITIONS AND METHODS FOR SELECTIVELY DEPLETING SENESCENT CELLS Bioventures, LLC. (US) 2017-06-14 EP disclosed
WO-2016014625-A1 COMPOSITIONS AND METHODS FOR SELECTIVELY DEPLETING SENESCENT CELLS BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) 2016-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10071087-B2 Compositions and methods for selectively depleting senescent cells CD47, MCL1, LIMS1 ALDH1A1 1334/4885KDM4E 495/4885HTR1A 4191/4885
US-10758524-B2 Compositions and methods for selectively depleting senescent cells CD47, MCL1, LIMS1 ALDH1A1 1334/4885KDM4E 495/4885HTR1A 4191/4885
US-20170246155-A1 COMPOSITIONS AND METHODS FOR SELECTIVELY DEPLETING SENESCENT CELLS CD47, MCL1, LIMS1 ALDH1A1 1334/4885KDM4E 495/4885HTR1A 4191/4885
US-20180369223-A1 COMPOSITIONS AND METHODS FOR SELECTIVELY DEPLETING SENESCENT CELLS CD47, MCL1, LIMS1 ALDH1A1 1334/4885KDM4E 495/4885HTR1A 4191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.